Baseline endometrial assessment before tamoxifen for breast cancer in asymptomatic menopausal women

Menopausal women with estrogen receptor-positive breast cancer appear to have high risk of baseline subclinical endometrial abnormalities; therefore, an endometrial assessment, before the start of tamoxifen therapy, is always recommended in such patients.